David Madtes, M.D.

David Madtes M.D.
faculty member

David Madtes, M.D.

Member/Section Head, Pulmonary and Critical Care Medicine
Clinical Research Division, Fred Hutch

Fax: 206.667.5765
Mail Stop: D3-190

Dr. David Madtes is a pulmonary and critical care specialist who treats and studies pulmonary problems among cancer patients. He is the director of the Seattle Cancer Care Alliance’s Lung Cancer Early Detection & Prevention Clinic at Seattle Cancer Care Alliance, Fred Hutch’s clinical care partner. The clinic is one of only a few in the nation that assesses people’s risk of lung cancer and expedites evaluations of suspicious findings using state-of-the-art diagnostic techniques. Dr. Madtes also founded and directs a joint SCCA/UW Medicine lung cancer screening program designed to detect lung cancer at its earliest stages when the chance of cure is highest. A primary goal of his research is to identify and address the barriers to lung cancer screening, especially in underserved populations. A second research focus is the application of artificial intelligence to improve the identification of early lung cancer on screening CT scans. A third goal of his research program is to identify and characterize noninfectious pulmonary complications of blood stem cell transplantation.

Other Appointments & Affiliations

Associate Professor, Pulmonary, Critical Care and Sleep Medicine
University of Washington


M.D., (Alpha Omega Alpha) Medical School, University of Pittsburgh School of Medicine, 1979

B.A., (Phi Beta Kappa), Chemistry, Gettysburg College 1974

Research Interests

Understanding barriers to lung cancer screening especially among socioeconomically disadvantaged populations

Application of Artificial Intelligence to risk stratify lung nodules concerning for early lung on screening CT scans.

Incidence and outcomes of Idiopathic Pneumonia Syndrome after hematopoietic stem cell transplantation

Current Projects

Tobacco education, smoking cessation and lung cancer screening among the indigenous communities of Western Washington

Clinical validity of an imaging software platform in predicting the probability of malignancy for pulmonary nodules.


"It’s been a real push to improve outcomes in advanced stage disease. With better early detection, we’ll be able to surgically remove tumors before they advance. That’s where the cure is.”

 —Dr. David Madtes

Find A Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210